e-learning
resources
Barcelona 2010
Monday, 20.09.2010
Clinical tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
In silico model of the spectrum of reactivity to mycobacteria
M. Amicosante, E. Puxeddu, M. Pallante, A. Comandini, C. Saltini (Rome, Italy)
Source:
Annual Congress 2010 - Clinical tuberculosis
Session:
Clinical tuberculosis
Session type:
Thematic Poster Session
Number:
3191
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Amicosante, E. Puxeddu, M. Pallante, A. Comandini, C. Saltini (Rome, Italy). In silico model of the spectrum of reactivity to mycobacteria. Eur Respir J 2010; 36: Suppl. 54, 3191
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Pulmonary sarcoidosis
Definition and history of sarcoidosis
Related content which might interest you:
In silico analysis of tuberculosis and multiple sclerosis gene expression profiles reveals coregulated genes implicated in host response to pathogens.
Source: International Congress 2017 – Human susceptibility to tuberculosis
Year: 2017
Design of immunogenic multiepitopic
mycobacterium tuberculosis
peptides from genes selected using
in vitro
models of mycobacterial macrophage infection
Source: Eur Respir J 2007; 30: Suppl. 51, 493s
Year: 2007
A standardised method for interpreting the association between mutations and phenotypic drug resistance in
Mycobacterium tuberculosis
Source: Eur Respir J, 50 (6) 1701354; 10.1183/13993003.01354-2017
Year: 2017
A proteomics approach for the identification of species-specific immunogenic proteins in the Mycobacterium abscessus complex
Source: International Congress 2019 – Infection and inflammation in cystic fibrosis
Year: 2019
Comparative analysis of M. tuberculosis drug susceptibility tests results in new multidrug-resistant tuberculosis cases and their confirmed contacts.
Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Year: 2020
Defining optimal fluoroquinolone exposure against
Mycobacterium tuberculosis
: contribution of murine studies
Source: Eur Respir J, 57 (4) 2004315; 10.1183/13993003.04315-2020
Year: 2021
Investigation and functional enrichment analysis of the human gene interaction network with common gram-negative respiratory pathogens predicts possible association with lung adenocarcinoma.
Source: International Congress 2019 – Crosstalk in chronic pulmonary diseases
Year: 2019
Systematic evaluation of clarithromycin (CLA) resistance associated mutations in Mycobacterium abscessus complex based on whole-genome sequencing analysis and drug susceptibility testing.
Source: Virtual Congress 2020 – Translational science in respiratory infections
Year: 2020
Comparative analysis of detection of Mycobacterium tuberculosis and rifampin resistance determination through microbiological and molecular genetics methods for pulmonary tuberculosis patients with presence or absence of sputum
Source: Annual Congress 2012 - Microbiological advances in the diagnosis of tuberculosis
Year: 2012
Breathprinting of multiple bacterial lung pathogens in vitro and in mice: what we can learn from translational approaches
Source: International Congress 2014 – Usefulness of exhaled volatile organic compounds (VOCs) for the monitoring and understanding of lung diseases
Year: 2014
A new mathematical model to identify contacts with recent and remote latent tuberculosis
Source: ERJ Open Res, 5 (2) 00078-2019; 10.1183/23120541.00078-2019
Year: 2019
High-resolution quantitative proteomics applied to the discovery of biomarkers of innate immune response in tuberculosis.
Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools
Year: 2018
IFN-gamma production in response to RD1 assays correlate with TST size and with the frequency of exposure to the index case in contacts recently exposed to
mycobacterium tuberculosis
Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care
Year: 2007
PCR based method for accurate diagnosis of mycobacterial disease and description of clinical profile of disease caused by non tuberculous mycobacteria
Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings
Year: 2012
Quantitative membrane proteomics reveals new functions ofCD13 in mycobacterium tuberculosis infection
Source: International Congress 2015 – Biomarkers in TB: immunology and physiology
Year: 2015
Comparison of
Mycobacterium tuberculosis
drug susceptibility tests by nucleic acid amplification and classic technique
Source: Eur Respir J 2001; 18: Suppl. 33, 315s
Year: 2001
Deficient
in silico
selection of
Mycobacterium tuberculosis
epitopes by an HLA susceptible allele
Source: Annual Congress 2005 - Genetics and immunobiology of tuberculosis
Year: 2005
In vitro
immune response to
Mycobacterium tuberculosis
antigens
Source: Eur Respir J 2005; 26: Suppl. 49, 22s
Year: 2005
A fully molecular drug sensitivity pattern for M.tuberculosis complex: what is available today and what is in the pipeline
Source: International Congress 2017 – How to manage difficult tuberculosis cases: diagnosis and treatment
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept